Businesses and Consumers Poised for Growth Amid Evolving Federal and State Alignment, summarized here:

• Federal Rescheduling to Schedule III: President Trump’s December 2025 executive order directs swift completion of moving cannabis from Schedule I to Schedule III, recognizing medical use and lower abuse risk; this aligns with Missouri’s legal market but maintains federal controls—no interstate trade or license cap changes.
  
• Tax Relief for Operators: Rescheduling lifts IRS Section 280E restrictions, allowing full deduction of business expenses (rent, ads, utilities); Missouri businesses could see ~30% profit boost and ~$150M statewide annual cash flow gain for reinvestment, without altering state taxes.
  
• Improved Research & Banking Access: Easier federal research approvals and greater legitimacy for banks reduce industry barriers; state rules on testing, tracking, sales, and no dispensary credit cards remain unchanged under DHSS oversight.
  
• Tighter Hemp Regulation: Federal November 2025 updates set <0.3% total THC and 0.4 mg THC/container caps, spurring Missouri bills to ban intoxicating derivatives (e.g., delta-8/THCa); unregulated smoke-shop products phase out, shifting sales to licensed dispensaries with mandatory testing/labeling for safety.
  
• Limited Immediate State Changes, Future Potential: Missouri’s medical/recreational protections, possession limits, patient cards, home grow, and expungements stay intact; long-term, reduced stigma may spur reforms like license expansion or home-grow tweaks, building a stronger regulated market.